Cotton, Deborah, M.D., M.P.H.

Medical School: Boston University School of Medicine
Residency training: Beth Israel Hospital, Boston
Fellowship training: National Institute of Allergy and Infectious Diseases, and the National Cancer Institute
MPH: John Hopkins University

Dr. Deborah Cotton is Professor of Medicine at the Boston University School of Medicine and Professor of Epidemiology at the Boston University School of Public Health. Recruited to the Boston University Medical Campus from the Massachusetts General Hospital in 1998, she has served as Assistant Provost for Clinical Research, founding Director of the Office of Clinical Research, and Chief, Medical Service, VA Boston Healthcare System. Dr. Cotton’s research focuses on the clinical epidemiology of HIV/AIDS other infectious diseases. She has been a member of the AIDS Clinical Trials Group (ACTG) since 1986. Dr. Cotton has served on numerous national committees including the FDA Antiviral Advisory Committee (member and chair), the Board on Health Sciences Policy of the Institute of Medicine, and the NIH Office of AIDS Research Advisory Council. She is the immediate past chair of the National and Global Public Health Committee of the Infectious Diseases Society of America (IDSA) and a current member of the IDSA’s Center for Global Health Scientific Advisory Committee and a charter member of the AIDS Clinical Epidemiology Study Section at the NIH. Dr. Cotton is a Deputy Editor of the Annals of Internal Medicine and a directly-elected Fellow of the American College of Physicians.


Selected Publications (from PubMed):

  1. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg MD, Boardman KD, Willams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachuki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh S-S, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan ISF, Wang WWB, Annunziato PW, and Silber JL for the Shingles Prevention Study Group. Varicella-Zoster Vaccine to Prevent Herpes Zoster. N Engl J Med. 2005; 352(22):2271-84.
  2. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan ISF, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; the Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators [Cotton DJ]. Varicella-Zoster Virus-Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine. J. Infect.Dis. 2008; 197(6):825-35.
  3. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM; Shingles Prevention Study Group [Cotton DJ]. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol. 2009 Jul; 81(7):1310-22.
  4. Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Camerson EDW, Brown ST; OPTIMA Team 1 [Cotton D]. Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS–defining events and non-AIDS serious adverse events. J. Acquir Immune Defic.Syndr. 2009; 51(5):631-9.
  5. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators [Cotton DJ]. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009; 200(7):1068-77.
  6. Nunes D, Fleming C, Offner G, Fix O, Koziel M, Graham C, Horsburgh CR, Cotton D. Non-Invasive Markers of Liver Fibrosis are Highly Predictive of Liver-Related Death in a Cohort of HCV Infected Individuals with and without HIV Infection. Am J Gastroenterol. 2010; 105(6):1346-53.
  7. Talbot TR, Babcock H, Caplan AL, Cotton D, Maragakis LL, Poland GA, Septimus EJ, Tapper ML, Weber DJ. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect. Control Hosp. Epidemiol. 2010; 31(10):987-95.
  8. Schmader KE, Johsnon GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, Chan IS, Yeh SS, Levin MJ, Harbecke RM, Oxman M, Shingles Prevention Study Group [Cotton DJ]. Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality –of-life measures in older adults. J. Am. Geriatr Soc. 2010; 58(9):1634-41. (Comment in J. Am. Geriatr Soc. 2010; 58(9):1799-800)
  9. Tobler WD Jr, Cotton D, Lepore T, Agarwal S, Mahoney EJ. Case report: Successful non-operative management of spontaneous splenic rupture in a patient with babesiosis. World J Emerg Surg. 2011; 6:4.
  10. Perkins RB, Langrish SM, Cotton DJ, Simon CJ. Maternal support for Human Papilloma Virus Vaccine in Honduras. J Womens Health (Larchmt). 2011 Jan; 20(1):85-90.
  11. Garg S, Hoenig M, Bliss C, Edwards E, Heeren T, Tumilty S, Horsburgh CR, Skolnik PA, Koziel M, Cotton D. Incidence and Predictors of Acute Renal Failure in an Urban Cohort of Subjects with HIV and Hepatitis C Co-infection.  AIDS Patient Care STDS. 2011 Mar; 25(3):135-41.
  12. O’Donnell MR, Coe A, Bliss C, Lee D, Tumilty S, Skolnik P, Horburgh CR, Cotton D, Saukkonen J. Acceptance of an Interferon-Gamma Release Assay by a high risk urban cohort. Int. J. Tuberc. and Lung Dis. (In Press)
Primary teaching affiliate
of BU School of Medicine